Literature DB >> 28989853

Xenotransplantation: Where Are We with Potential Kidney Recipients? Recent Progress and Potential Future Clinical Trials.

Kazuhiko Yamada1, Jigesh A Shah2, Tatsu Tanabe1, Miguel A Lanaspa3, Richard J Johnson3.   

Abstract

PURPOSE: Inter-species transplantation, xenotransplantation, is becoming a realistic strategy to solve the organ shortage crisis. Here we focus on seminal publications that have driven research in xenotransplantation, as well as recently published literature and future endeavors. RECENT
FINDINGS: Advances in gene editing technology have allowed for the efficient production of multi-transgenic porcine donors leading improved xenograft survival in baboons, up to 2-years following heterotopic heart xenotransplantation and from weeks to several months following life-supporting kidney xenotransplanation. As technology evolves, additional challenges have arisen, including the development of proteinuria, early graft loss associated with porcine CMV, disparities in organ growth between donors and recipients as well as high-dose continuous immunosuppression requirements. To address these issues, our laboratory developed a tolerance-inducing protocol which has allowed for >6 months survival of a life-supporting kidney with further approaches currently underway to address the challenges mentioned above.
SUMMARY: Our recent findings, reviewed in this article, led us to develop methods to overcome obstacles, which, in conjunction with the work of others, are promising for future clinical applications of xenotransplantation.

Entities:  

Year:  2017        PMID: 28989853      PMCID: PMC5625292          DOI: 10.1007/s40472-017-0149-6

Source DB:  PubMed          Journal:  Curr Transplant Rep


  65 in total

1.  A Bridge to Somewhere: 25-day Survival After Pig-to-Baboon Liver Xenotransplantation.

Authors:  Jigesh A Shah; Nalu Navarro-Alvarez; Matthew DeFazio; Ivy A Rosales; Nahel Elias; Heidi Yeh; Robert B Colvin; A Benedict Cosimi; James F Markmann; Martin Hertl; David H Sachs; Parsia A Vagefi
Journal:  Ann Surg       Date:  2016-06       Impact factor: 12.969

2.  Xenograft rejection of porcine islet-like cell clusters in immunoglobulin- or Fc-receptor gamma-deficient mice.

Authors:  B Benda; A Karlsson-Parra; A Ridderstad; O Korsgren
Journal:  Transplantation       Date:  1996-11-15       Impact factor: 4.939

3.  Podocytes are nonhematopoietic professional antigen-presenting cells.

Authors:  Andreas Goldwich; Miriam Burkard; Martha Olke; Christoph Daniel; Kerstin Amann; Christian Hugo; Christian Kurts; Alexander Steinkasserer; André Gessner
Journal:  J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 10.121

4.  Identification and characterization of a novel hepatic canalicular ATP diphosphohydrolase.

Authors:  J Sévigny; S C Robson; E Waelkens; E Csizmadia; R N Smith; R Lemmens
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

5.  Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning.

Authors:  Liangxue Lai; Donna Kolber-Simonds; Kwang-Wook Park; Hee-Tae Cheong; Julia L Greenstein; Gi-Sun Im; Melissa Samuel; Aaron Bonk; August Rieke; Billy N Day; Clifton N Murphy; David B Carter; Robert J Hawley; Randall S Prather
Journal:  Science       Date:  2002-01-03       Impact factor: 47.728

6.  Production of alpha 1,3-galactosyltransferase-deficient pigs.

Authors:  Carol J Phelps; Chihiro Koike; Todd D Vaught; Jeremy Boone; Kevin D Wells; Shu-Hung Chen; Suyapa Ball; Susan M Specht; Irina A Polejaeva; Jeff A Monahan; Pete M Jobst; Sugandha B Sharma; Ashley E Lamborn; Amy S Garst; Marilyn Moore; Anthony J Demetris; William A Rudert; Rita Bottino; Suzanne Bertera; Massimo Trucco; Thomas E Starzl; Yifan Dai; David L Ayares
Journal:  Science       Date:  2002-12-19       Impact factor: 47.728

7.  Results of life-supporting galactosyltransferase knockout kidneys in cynomolgus monkeys using two different sources of galactosyltransferase knockout Swine.

Authors:  Mitsuhiro Sekijima; Shiori Waki; Hisashi Sahara; Masayuki Tasaki; Robert A Wilkinson; Vincenzo Villani; Yoshiki Shimatsu; Kazuaki Nakano; Hitomi Matsunari; Hiroshi Nagashima; Jay A Fishman; Akira Shimizu; Kazuhiko Yamada
Journal:  Transplantation       Date:  2014-08-27       Impact factor: 4.939

Review 8.  The use of CRISPR/Cas associated technologies for cell transplant applications.

Authors:  Peter J Cowan
Journal:  Curr Opin Organ Transplant       Date:  2016-10       Impact factor: 2.640

9.  Identification of alpha-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man.

Authors:  D K Cooper; A H Good; E Koren; R Oriol; A J Malcolm; R M Ippolito; F A Neethling; Y Ye; E Romano; N Zuhdi
Journal:  Transpl Immunol       Date:  1993       Impact factor: 1.708

10.  Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft.

Authors:  Muhammad M Mohiuddin; Avneesh K Singh; Philip C Corcoran; Marvin L Thomas Iii; Tannia Clark; Billeta G Lewis; Robert F Hoyt; Michael Eckhaus; Richard N Pierson Iii; Aaron J Belli; Eckhard Wolf; Nikolai Klymiuk; Carol Phelps; Keith A Reimann; David Ayares; Keith A Horvath
Journal:  Nat Commun       Date:  2016-04-05       Impact factor: 14.919

View more
  2 in total

Review 1.  IXA Honorary Member Lecture, 2017: The long and winding road to tolerance.

Authors:  Megan Sykes
Journal:  Xenotransplantation       Date:  2018-05       Impact factor: 3.907

Review 2.  Transplanting organs from pigs to humans.

Authors:  Megan Sykes; David H Sachs
Journal:  Sci Immunol       Date:  2019-11-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.